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A proteomic approach for fast identification of 
Staphylococcus aureus isolates by Matrix Assisted Laser 
Desorption Ionization Time of Flight (MALDI-TOF) 
based protein mass fingerprinting 
 
 
Khaled A. Abdallah 
 
Abstract 
 
              Staphylococcus aureus is an important human pathogen 
that is capable of causing a wide range of diseases, from relatively 
mild skin infections to deep systemic infections such as 
pneumonia. Identification and typing of S. aureus is currently 
based on various genomic and phenotypic methods; however, these 
methods are time-consuming, expensive and sometimes lack 
accuracy. A total of 14 S. aureus isolates were previously 
identified by conventional methods including multiple locus 
sequence typing (MLST), SCCmec typing and spa typing. Our 
purpose is to evaluate the use of Matrix Assisted Laser Desorption 
Ionization Time of Flight (MALDI-TOF) for rapid identification 
and analysis of these S. aureus isolates. Formic acid extraction was 
used to extract proteins which were then subjected to MALDI-TOF 
analysis. An identification profile for each isolate was created and 
2 programs were developed for further analysis of the obtained 
data. With this approach setting stringent parameters on 
reproducibility of data, we were able to identify the masses of 5 
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peaks (4823, 6428, 6612, 8903, and 9644 m/z) that are common to 
all S. aureus isolates. To determine whether these 5 peaks were 
unique to S. aureus, the same procedure of protein extraction and 
data analysis was applied on S. epidermidis and Escherichia coli. 
Compared to the m/z list of S. aureus, 3 peaks were discovered to 
be common in S. epidermidis but none in E. coli. Thus we were 
able to identify 3 peaks unique for the genus Staphylococcus and 2 
peaks unique for the species S. aureus. Also, our results suggest 
that the program developed is valid and very powerful in analyzing 
high-through put data obtained from MALDI analysis. Moreover, 
MALDI-TOF MS has high potential to be used as a proteomic tool 
for the identification of bacteria. Future work includes 
identification of peaks specific at the strain level and Tandem-MS 
of the unique peaks to determine their nature.   
 
Keywords: Staphylococcus aureus, Matrix Assisted Laser 
Desorption Ionization Time of Flight (MALDI-TOF), Mass 
Spectrometry, Proteomics, Genomics, m/z value.
 ix 
 
TABLE OF CONTENTS 
 
Chapter Page 
 
I. INTRODUCTION                                                                                  1 - 15 
 
1.1 Overview of Staphylococcus aureus                                                    1 
1.2 Pathogenesis of Infection                 2 
1.3 Virulence Factors                                                                                  3 
1.4 Molecular Typing of Staphylococcus aureus                                       5 
1.4.1 spa Typing                7 
1.4.2 Multi-Locus Sequence Typing                8 
1.4.3 Pulsed Field Gel Electrophoresis                9 
 
1.5 Characterization of Pathogens using MALDI                                    10 
1.6 Identification and Typing of S. aureus using MALDI                       14 
 
II. MATERIALS AND METHODS                                                        16 - 23 
 
2.1 Clinical Isolates              16 
2.2 MALDI-TOF-MS                                                                               20 
2.3 Calibration and Error Analysis                                                           21 
2.4 Development of Program for High Throughput Data Analysis   22 
 
III. RESULTS                                                                                              24 - 32 
 
3.1 Identification of Discriminatory m/z Values of S. aureus              24 
 x 
 
3.2 Data Analysis of Mass Spectra                                                           25 
3.3 Data Validation and Analysis                                                             28 
3.4 Identification of Discriminatory m/z Values of  S. epidermidis  and E. 
coli                                                                                                             29 
 
IV. DISCUSSION                                                                                       33 – 39 
 
V. CONCLUSION                                                                                            40 
 
VI. BIBLIOGRAPHY                                                                                 41 - 52 
 
VII. APPENDICES                                                                                       53 - 62 
Appendix I                  53 
Appendix II                                                                                                                 58 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
 
LIST OF TABLES 
 
Table  Page 
 
Table 1. “An overview of the major MRSA and MSSA spa types and their 
corresponding MLST clones recovered from Lebanon”                                  18 
 
Table 2. 4700 Cal Mix Internal standards used for instrument calibration        22 
 
Table 3.  Masses observed for each S. aureus isolate from MALDI-TOF-MS 
analysis                                                                                                             26 
Table 4. List of m/z values common in each type of bacteria                            30 
 
Table 5. Comparison between E. coli peaks derived from our study to ribosomal 
proteins determined by Freiwald et al. (2009)                                                    31 
 
Table 6. Highlighted peaks represent the similarity identified between S. aureus 
and S. epidermidis                                                                                               32 
 
 
 
 
 
 
 
 
 xii 
 
LIST OF FIGURES 
 
Figure                                                  Page 
 
Figure 1. Schematic overview of the ionization method                                    10 
Figure 2. 4800 MALDI TOF/TOF analyzer                                                       11 
Figure 3. MALDI-TOF MS spectrum of S. aureus isolate (SA 94)                 25 
Figure 4. Spectrum showing common peaks for all 14 S. aureus isolates         28 
Figure I-a. Layout of the first step to be applied in program 1                           53 
Figure I-b. Layout of the second step to be applied in program 1                      54 
Figure I-c. Layout of the first step to be applied in program 2                           55 
Figure I-d. Layout of the second step to be applied in program 2                      56 
Figure I-e. Layout of the third step to be applied in program 2                          57 
Figure II-a. MALDI-TOF MS spectrum of S. aureus isolate (SA 128)          58 
Figure II-b MALDI-TOF MS spectrum of S. aureus isolate (SA 36)           59 
Figure II-c MALDI-TOF MS spectrum of S. aureus isolate (SA 34)                60 
Figure II-d MALDI-TOF MS spectrum of S. aureus isolate (SA 24)           61 
Figure II-e MALDI-TOF MS spectrum of S. aureus isolate (SA 95)                62 
Figure II-f MALDI-TOF MS spectrum of S. aureus isolate (SA 23)                63 
Figure II-g MALDI-TOF MS spectrum of S. aureus isolate (SA 89)                64 
Figure II-h MALDI-TOF MS spectrum of S. aureus isolate (SA 57)                65 
Figure II-i  MALDI-TOF MS spectrum of S. aureus isolate (SA 79)                66 
Figure II-j  MALDI-TOF MS spectrum of S. aureus isolate (SA 16)                67 
Figure II-k MALDI-TOF MS spectrum of S. aureus isolate (SA 103)           68 
Figure II-l  MALDI-TOF MS spectrum of S. aureus isolate (SA 125)          69 
Figure II-m MALDI-TOF MS spectrum of S. aureus isolate (SA 126)          70 
 xiii 
 
Figure II-n MALDI-TOF MS spectrum of Escherichia coli J96)                      71 
Figure II-o MALDI-TOF MS spectrum of Staphylococcus epidermidis 80      72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv 
 
GLOSSARY 
 
CA-MRSA: community-acquired methicillin-resistant Staphylococcus aureus  
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Chapter One 
 
INTRODUCTION 
 
1.1 Overview of Staphylococcus aureus 
 
 
Staphylococcus aureus is a facultative anaerobic gram-positive 
bacterium that has been discovered in Aberdeen, Scotland, in 1880 by 
the surgeon Sir Alexander Ogston. In 1884, Rosenbach isolated and 
cultured these bacteria from abscesses and entitled them S. aureus 
because of the yellow-orange or „„gold‟‟ pigmented appearance of the 
colonies, thus the Latin word „„aureus‟‟ (van Belkum et al., 2009). S. 
aureus are non-spore forming cocci characterized by their non-
flagellated, spherical structure and resemble grapelike structures 
when observed under the microscope (Seybold et al., 2006). 
Moreover, they are known to be catalase-positive (Todar, 2008) with 
an optimal growth temperature between 15 to 45 °C. The majority of 
S. aureus strains are opportunistic pathogens that colonise the human 
skin and nares for either a short or extended periods of time without 
showing any symptoms. However, once the immune system of the 
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individual becomes compromised, infection is inevitable (Oliveira, 
Milheirico, & de Lencastre, 2006). 
 
Since its discovery, S. aureus was found to be an important cause of 
serious community and health-care-associated infections (Thwaites et 
al., 2011). Such infections can range from relatively minor infections 
of the skin to life-threatening conditions such as wound infections, 
bacteraemia, infections of the central nervous system, respiratory and 
urinary tracts, and infections associated with intravascular devices 
and foreign bodies (Oliveira et al., 2006). 
 
 
1.2 Pathogenesis of Infection 
 
 
S. aureus infections occur after several phases of pathogenesis. Initial 
colonization of the bacteria can lead to local sores of skin. The 
infection can remain local or disseminate to reach the bloodstream, 
facilitating metastasis into any organ. Afterwards, toxinosis or septic 
shock can develop. If not treated properly, these systemic infections 
result in high mortality rates. In addition, S. aureus toxins can lead to 
serious disorders without the necessity of bacterial invasion into the 
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bloodstream, such as toxic shock syndrome and scalded skin 
syndrome. Therefore, the control of virulent S. aureus infections is of 
major significance (Archer, 1998). 
 
 
1.3 Virulence Factors 
 
 
Increases in the mortality and morbidity rate in hospitals worldwide 
have been associated with the emergence of Methicillin-resistant S. 
aureus (MRSA) strains (Wolters et al., 2011). MRSA strains have 
developed due to the presence of mecA gene, that codes for altered 
penicillin-binding protein (PBP2a) which in turn has a decreased 
affinity to β-lactam antibiotics (Makgotlho et al., 2009; Decker, 
2008). mecA is located on a mobile genetic element called 
staphylococcal cassette chromosome mec (SCCmec) (Makgotlho et 
al., 2009). Among the eight identified types of SCCmec (I-VIII) 
(Chambers & Deleo, 2009), community acquired MRSA (CA-
MRSA) mostly possesses the type IV or V, while hospital acquired 
MRSA (HA-MRSA) contain types I, II, and III (Decker, 2008).  
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S. aureus’ capability to produce many virulence factors contribute to 
its high pathogenicity (Palavecino, 2007). Panton-Valentine 
leukocidin (PVL) is one of the virulence factors engaged in the 
pathogenesis of most S. aureus infections (Gillet et al., 2002). PVL is 
an exotoxin that is considered a genetic indicator for CA-MRSA 
strains, which causes more severe diseases than HA-MRSA due to 
the production of this toxin (Vandenesch et al., 2003). Other than 
CA-MRSA infections, the importance of PVL lies in its association 
with necrotizing pneumonia and skin infections, such as cutaneous 
abscesses and cellulitis (Labandeira-Rey et al., 2007). PVL belongs 
to the synergohymenotropic toxins family where it damages 
neutrophils by forming pores in membranes through the synergistic 
process of two unrelated proteins, LukS-PV and LukF-PV (Genestier 
et al., 2005).  
 
An essential virulence factor found in all S. aureus strains is the 
Staphylococcal protein A (Spa). Protein A is 42-kD bound to the cell 
wall whereas its extracellular portion binds the Fc-region of 
immunoglobulin IgG of diverse mammalian species (Patel, Nowlan, 
Weavers, & Foster, 1987). Protein A plays important roles in S. 
aureus pathogenesis by preventing phagocytosis, stimulating B 
lymphocytes proliferation, and inducing inflammatory reactions in 
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airways and corneal epithelial cells (Gustafsson et al., 2009). Other 
virulence factors of S. aureus include the toxic shock syndrome 
toxin-1 (TSST-1) and the enterotoxins which stimulate the release of 
massive amounts of cytokines, such as interleukins (IL) and tumor 
necrosis factors (TNF), resulting in toxic shock (McCormick, 
Yarwood, & Schlievert, 2001). 
 
 
1.4 Molecular Typing of S. aureus 
 
 
To perform effective control measures against the wide spread of S. 
aureus infections, it is essential to distinguish between not only 
sporadic and epidemic strains, but also to distinguish one epidemic 
clone from another (Jackson, Edwards-Jones, Sutton, & Fox, 2005). 
Therefore, a variety of phenotypic and genomic typing methods have 
been employed to differentiate among S. aureus strains (Feil & 
Enright, 2004). Selecting the appropriate technique is essential for 
tracking the epidemiology of MSSA and most importantly MRSA 
infections, investigating MRSA outbreaks, and consequently 
supporting control measures of S. aureus spread (Hallin et al., 2008). 
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Phenotypic methods have been widely used in the clinical settings to 
distinguish S. aureus isolates. The most frequently used phenotypic 
means is the antimicrobial susceptibility test which provides rapid 
and useful data. However, this method of typing lacks the precise 
discrimination between isolates because MRSA strains are resistant 
to most classes of antibiotics. Therefore, genotypic approaches are 
considered more reliable for MRSA strains characterization 
(Palavecino, 2007).  
 
The most common genotyping methods of S. aureus include single 
locus sequencing, such as staphylococcal protein A gene (spa) and 
coagulase gene (coa) typing, multilocus sequence typing (MLST), 
and pulsed-field gel electrophoresis (PFGE) (Turner & Feil, 2007). 
All of the above mentioned techniques achieve the ultimate purpose, 
which is subtyping of S. aureus strains, but each with a different 
discriminatory power, accuracy, and reproducibility (Weller, 2000).  
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1.4.1 spa Typing 
  
 
Spa typing technique is based on sequencing the polymorphic X 
region of a single hyper-variable locus of protein A gene (Crisostomo 
et al., 2001). It involves the analysis of sequence variation and repeat 
number that varies from 1 to 15, thus providing a binary typing 
scheme (van Belkum et al., 2009). Because this repeat region is 
highly subjected to spontaneous mutations, spa typing is considered 
useful and reliable to examine temporary and local MRSA outbreaks 
(Mellmann et al., 2006). Furthermore, spa typing is rapid, 
inexpensive, reproducible, and more resolving than coa typing 
(Harmsen et al., 2003). However, the strong resolving power of spa 
typing has become a drawback because even epidemiologically 
related strains are categorized as different through this technique due 
to the continuous sequence alterations (van Belkum et al., 2009).  
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1.4.2 Multi-Locus Sequence Typing  
 
 
Unlike spa typing, MLST is a molecular method that targets seven 
stable loci of housekeeping genes, useful for studying long-standing 
population relatedness and assessing the evolution of S. aureus 
strains. Each isolate is characterized by a sequence type (ST), which 
is a set of seven numbers representing the seven alleles of each locus 
(Enright, Day, Davies, Peacock, & Spratt, 2000). Closely related STs 
are classified in a clonal cluster (CC), providing a detailed 
phylogenetic tree of S. aureus population structures (Robinson & 
Enright, 2004). However, because MLST targets only housekeeping 
genes which belong to the core genome and far from frequent genetic 
variation, it is not reliable to discriminate epidemiologically unrelated 
strains or recognize local MRSA outbreaks in hospitals (Cooper & 
Feil, 2004). Another disadvantage of MLST lies in its high cost and 
the need of a sequencing facility, which is not often available in 
clinical settings (Harmsen et al., 2003). 
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1.4.3 Pulsed-Field Gel Electrophoresis  
 
 
Another genomic typing technique is the PFGE that is based on 
digesting bacterial chromosomal DNA with a rare cutting restriction 
endonuclease, producing a unique pattern of bands to each S. aureus 
strain (Palavecino, 2007; van Belkum et al., 2009). Compared to 
other typing methods, PFGE has been reported to possess a higher 
discriminatory power than spa typing and MLST to better investigate 
MRSA outbreaks in hospitals and study the population structure of S. 
aureus strains (Vainio et al., 2008). Although considered a “gold 
standard”, PFGE may not trace S. aureus long-term clones, due to the 
constancy of restriction sites (Hallin et al., 2008). Moreover, it is cost 
expensive, time consuming (Jackson et al., 2005), and requires high 
level of technical expertise (Carbonnelle et al., 2011). 
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1.5 Characterization of Pathogens using MALDI 
 
 
Matrix-assisted laser-desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) is known to be a “soft ionization” 
method producing ions from biological molecules such as proteins 
and DNA (Lay & Holland, 2000).  
 
 
  
Figure 1. Schematic overview of the ionization method 
 
 
The biological molecules are first crystallized with acidic organic 
particles known as the “matrix”. A pulsed laser will then irradiate 
these co-crystals at a wavelength near the resonant absorption band of 
the matrix molecules. Therefore stimulating energy transfer and 
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desorption process that lead to vaporization of the analyte and matrix 
molecules into a highly vacuumed gas phase. Next, a proton-transfer 
reaction between matrix and analyte is induced leading to singly 
charged ions that are then accelerated by an electric field toward a 
mass analyzer (Sauer, 2007). Ions are then separated based on their 
mass-dependent velocities and are characterized by: molecular mass 
(m), charge (z), mass to charge ratio (m/z), and a relative intensity of 
the signal (Carbonnelle et al., 2011).  
 
 
 
Figure 2. 4800 MALDI TOF/TOF analyzer 
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The method‟s high sensitivity, specificity, speed and reliability has 
endorsed its introduction into an increasing number of diagnostic 
laboratories worldwide (Christner et al., 2010). The increase of 
interest in time-of-flight mass spectrometry (TOF) has occurred in 
1988, after the invention of MALDI by Karas and Hillenkamp 
(1988). Later, Holland et al. (1996) were the first to illustrate the use 
of MALDI for the analysis of intact microbial cells. 
 
In recent years, several studies have shown that MALDI-TOF MS 
can be applied for the identification of diverse species and strains of 
bacteria (Yang et al., 2009). For example, this technique was applied 
on whole cells for the identification of major human pathogens such 
as Listeria and Pneumococci to the species level (Carbonnelle et al., 
2011) and for subspecies typing of Streptococcus pneumonia 
(Williamson et al., 2008). In addition, its differentiation among L. 
monocytogenes strains is also critical for proper therapy of listeriosis, 
a serious infection that affects pregnant women and immune-
compromised patients. Barbuddhe et al. (2008) have performed 
MALDI-TOF MS on bacterial extracts as a promising method to 
identify, fingerprint and discriminate the clonal lineages of the 
pathogenic L. monocytogenes. Corynebacterium is another toxigenic 
organism where MALDI-TOF MS can be applied to rapidly identify 
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between its different species, such as C. ulcerans, C. 
pseudotuberculosis and C. diphtheriae (Konrad et al., 2010). Veloo, 
Welling, & Degener, (2011) have reported the use of MALDI-TOF 
MS on whole cells for the identification of anaerobic bacteria whether 
being Gram-positive, such as Clostridium spp., or Gram-negative 
anaerobes, such as Prevotella spp., Fusobacterium spp., and 
Bacteroides spp. Moreover, fingerprints of unknown bacterial 
samples obtained from MALDI-TOF MS, can be accurately 
identified by comparing them with reference database of known 
bacteria (Holland et al., 1996; Stackebrandt, Pauker, & Erhard, 
2005). Ferreira et al. (2010) have reported the creation of MALDI 
reference database profiles for Brucella species, which is also a 
pathogenic microorganism in many countries.  This is useful for 
recognizing Brucella from culture plates and blood cultures bottles.  
 
Other than identification purposes for practice clinical microbiology, 
MALDI-TOF MS may assist in infection control measures 
(Barbuddhe et al., 2008; Carbonnelle et al., 2011). Other studies 
showed that MALDI-TOF was a powerful technique in identifying 
crystal (cry) toxins from different novel Bacillus thuringiensis (Bt) 
strains. Under normal circumstances, a successful PCR technique 
would be sufficient to detect the cognate genes of novel Cry toxins in 
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novel Bt strains; however when this failed, the MALDI-TOF MS 
emerged as a potent remedy. The MALDI-TOF MS of in-gel trypsin 
digested proteins was successfully used here to match the peptide 
masses to their corresponding proteins. The MALDI-TOF MS 
technique was very effective that it even helped in differentiating and 
detecting multiple Cry toxins from a single protein band, that are of 
very similar molecular weights and isoelectric points (Ranasinghe & 
Akhurst, 2002).  
 
 
1.6 Identification and typing of S. aureus using MALDI 
 
 
MALDI-TOF MS has been shown to be a powerful tool for 
identification of S. aureus (Meetani & Voorhees, 2005). Edwards-
Jones et al. (2000) showed that this technique can be applied directly 
on whole cells for the differentiation between methicillin-resistant 
and methicillin-sensitive S. aureus strains. They were able to identify 
peaks specific to MRSA, others specific to MSSA, and few specific 
to individual strains. Also, Du et al. (2002) showed similar results 
were whole cells of S. aureus strains harbouring the mecA were 
successfully detected by MALDI-TOF as MRSA, while those lacking 
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the resistant gene were successfully identified as MSSA. In addition, 
Wolters et al., (2011) have shown that MALDI-TOF MS of bacterial 
extracts has the ability to become an important screening tool for 
prediction of clonal lineages and outbreak investigations. In brief, 
they were able to identify 13 peaks differentiating between MRSA 
isolates belonging to the 5 major HA-MRSA clonal complexes (CC5, 
CC8, CC22, CC30, CC45).  
 
In this study, we utilized a total of 14 S. aureus strains already 
identified by regular genomic methods including PFGE, MLST, and 
spa typing. We propose a proteomic approach for fast identification 
of S. aureus isolates by MALDI-TOF MS based protein mass 
fingerprinting. Proteins were extracted using formic acid and they 
were subjected to MALDI-TOF analysis. The resulting identification 
profiles were analyzed using a newly developed program with strict 
parameters. Moreover, the same experimental procedure and data 
analysis were applied on two bacteria to assess the specificity of our 
proteomic approach. Bacteria used were S. epidermidis, the closest 
species to S. aureus, and E. coli, which belongs to a genus that is 
evolutionary far from Staphylococcus.  
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Chapter Two 
 
MATERIALS AND METHODS 
 
 
2.1 Clinical Isolates 
 
A total of 14 S. aureus isolates (10 MRSA and 4 MSSA), obtained 
from clinical specimens kindly provided by Dr. George Araj from 
American University Hospital (AUH) in Beirut, were used in this 
study. The list of isolates and their characteristics are found in table 1. 
Five isolates were recovered from wound infections, 2 from blood, 2 
from sputum, 1 from semen, 1 from eye, 1 from brain, 1 from Neck 
mucus, and 1 from descending thoracic aorta (DTA). The samples 
were streaked on Tryptone Soy Agar (TSA) and stored in Cryobanks 
at -80 °C. All isolates were previously characterized by spa typing, 
SCCmec typing and MLST. spa typing classified the isolates into 14 
different spa types, which could be designated to 9 different clonal 
complexes based on previously determined MLST typing data. Six of 
14 isolates belonged to the 4 major HA-MRSA clonal complexes 
CC5 (2 isolates), CC8 (1), CC22 (1), and CC30 (2). Two isolates 
were assigned to unrelated sporadic strain types, e.g. t044 (ST-80) 
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and t127 (ST-1) described as widely disseminated CA-MRSA clones. 
In addition, the study included Staphylococcus epidermidis 80 and 
Escherichia coli J96 ATCC.  
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Table 1: “An overview of the major MRSA and MSSA spa types and their corresponding MLST clones 
recovered from Lebanon” (Tokajian et al., 2010) 
Isolate 
SA 
SCCmec 
type1 
PVL2 
MLST 
ST3 
MLST 
CC4 
Allelic 
profile 
spa 
type 
spa-
CC5 
Pathogenic genes 
Site of 
Infection 
E-Test 
Susceptibility (#R) 
23 IVc + ST-80 CC80 
1-3-1-14-
11-51-10 
t 044 
spa-
CC044 
None Wound OX 
94 MSSA - ST-30 CC30 
2-2-2-2-6-
3-2 
t 012 
spa-
CC021 
SEA,SEG,SEI,TSST blood None 
89 MSSA - ST-80 CC80 
1-3-1-14-
11-51-10 
t 937 
spa-
CCd 
SEI wound TR, TS 
16 IVc + ST-30 CC30 
2-2-2-2-6-
3-2 
t 318 
spa-
CC021 
SED Wound NX, TC 
126 IVc - ST-8 CC8 
3-3-1-1-4-
4-3 
t 008 
spa-
CC008 
SEA, SEI, eta Semin AZ, CH 
95 MSSA - ST-1 CC1 
1-1-1-1-1-
1-1 
t 127 sg #2 SEC, SEI Wound AZ, CM, EM, TR 
79 MSSA - ST-5 CC5 
1-4-1-4-
12-1-10 
t 002 
spa-
CCb 
SEG,SEI Blood CH, LE, NX, OF, TC 
57 IVc + ST-80 CC80 
1-3-1-12-
11-51-10 
t 131 
spa-
CC044 
SEG,SEI Eye AZ, CM, EM, OX, TC 
24 III - 
ST-
239 
CC239 
2-3-1-1-4-
4-3 
t 037 
spa-
CC021 
SEA Brain 
AZ, CM, CL, EM, OX, 
TC 
103 IVc - ST-22 CC22 
7-6-1-5-8-
4-6 
t 032 
spa-
CC005 
SED,SEI Sputum 
CI, EM, NX, OF, OX, 
TC, VA 
125 IVc + ST-5 CC5 
1-4-1-4-
12-1-10 
t 311 
spa-
CCb 
SEA Sputum EM ,TC 
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Isolate 
SA 
SCCmec 
type1 
PVL2 
MLST 
ST3 
MLST 
CC4 
Allelic 
profile 
spa 
type 
spa-
CC5 
Pathogenic genes 
Site of 
Infection 
E-Test 
Susceptibility (#R) 
34 V - ST 97 CC 97 
3-1-1-1-1-
5-3 
t 267 sg #6 None 
Neck 
mucus 
OX, TC 
98 MSSA + 
ST 
121 
CC 
121 
6-5-6-2-7-
14-5 
t 159 sg #3 SEB,SEG,SEI BRW None 
36 III - 
ST 
239 
CC239 
2-3-1-1-4-
4-3 
t 030 
spa-
CC021 
None Wound 
AZ, CH, CM, CL, EM, 
GM, LE, NX, OF, OX, 
RI, TC, TR, TS 
128 IVc - ST 6 CC 6 
12-4-1-4-
12-1-3 
t 304 
spa-
CC008 
SEA,eta DTA None 
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2.2 MALDI-TOF MS 
 
 
For sample preparation, formic acid extraction of bacteria was carried 
out using a modified protocol by Wolters et al. 2011. In brief, 
bacterial sample were cultured on TSA plates for 22-24 h at 37 °C. A 
full loop of colonies was then suspended in 300 µL of sterile water. 
900 µL of ethanol were then added and the mixture is vortexed. The 
suspended bacteria were then centrifuged at 12,000×g for 2 min at 
room temperature. Discard the supernatant and centrifuge again to 
remove any residual ethanol. The pellet was then resuspended in 50 
µL of formic acid (70%) and 50 µL of acetonitrile. Centrifugation 
was then applied at maximum speed for 2 minutes and 80 µL of the 
supernatant were collected and stored and stored at −20 ºC until use. 
For plate preparation, 1 µL aliquots of the supernatant was spotted 
onto a stainless steel target plate (Opti-TOF 
TM 
384 Well Insert, 
123×81 mm RevA, Applied Biosystems, USA) and air dried for 15 
min. 1 µL of matrix solution (saturated solution of α-cyano-4-
hydroxy-cinnamic acid in 50% acetonitrile with 2.5% trifluoroacetic 
acid) was added to each sample spot and again air dried for 15 min. 
MALDI-TOF analysis was applied on a 4800 MALDI TOF/TOF 
Analyzer instrument operated by the 4000 Series Explorer software 
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(Applied Biosystems, USA). Spectra were acquired in linear positive 
mode at a laser intensity of 7540 within a mass range from 800 to 
20,000 Da. Acceleration voltage was 20 kV, IS2 voltage was 
maintained at 19.3 kV, and the extraction delay time was 160 ns. For 
each sample spot, one average spectrum was accumulated from 500 
measurements. For each of the 14 isolates, 3 extracts were generated 
from independent subcultures. Each extract was analyzed in 
multiplets (11 per each), resulting in 33 mass spectra for each isolate 
and a total of 560 mass spectra for the whole study. 
 
 
2.3 Calibration and Error Analysis 
 
 
Calibration was performed using Applied Biosystems 4700 
Proteomics Analyzer Calibration mixture. The internal standards used 
and their average theoretical mass are listed in Table 2. The 
percentage error was calculated by comparing measured values of 
4700 Cal Mix standard (Linear mode) to their theoretical one. Also, 
Table 2 exemplifies how the percentage error was calculated for each 
experiment. 
  
 
 
 22 
 
Table 2. 4700 Cal Mix Internal standards used for instrument calibration 
Internal Standards Theoretical 
Mass (Da) 
Average 
Measured Mass 
(Da) 
Error 
(ppm) 
% Error 
des-Arg-Bradykinin 904.4681 904.6936 249.32 0.02 
Angiotensin 1 1296.6853 1297.7828 846.38 0.09 
Glu-Fibrinopeptide B 1570.6774 1572.2834 1022.48 0.10 
ACTH (clip 1-17) 2093.0867 2.09E+03 756.39 0.08 
ACTH (clip 18-39) 2465.1989 2468.0046 1138.12 0.11 
ACTH (clip 7-38) 3657.9294 3663.185 1436.76 0.14 
   
 
 
2.4 Development of Program for High Throughput Data Analysis  
 
 
Mass spectrum analysis was performed using two programs (Program 
1 and Program 2) developed by Engineer Mazen Naamani. Strict 
parameters were set on the developed program to ensure minimum 
error during data analysis. Briefly, Program 1 is concerned with 
analysis of centroid mass peaks obtained from a single isolate. The 
input will represent the 33 peak lists obtained from each isolate 
(Figure I-a in appendix I). The output will represent a peak list 
containing centroid masses detected with their percentage of 
occurrence in the 33 runs (Figure I-b in appendix I). Program 2 is 
concerned with analysis of data between all the isolates. The input in 
this program is the output of all the isolates from program 1 (Figure I-
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c in appendix I). At this stage, the program will collect all the 
centroid masses from all the peak lists and search for their occurrence 
in all the isolates. This will result in a new sheet that shows all the 
centroid masses with their percentage of occurrence in each isolate 
(Figure I-d in appendix I). Then an averaging process will take place 
where peaks are averaged based on the following criteria: a) they are 
within the determined percentage error, b) they follow same trend of 
occurrence and percentage among the 14 isolates. The last step of 
data analysis is concerned with selecting peaks present in all 14 S. 
aureus isolates (Figure I-e in appendix I). We set the selection 
process based on the follow criteria: a) Centroid mass in each isolate 
showing a percentage of occurrences less than 15% is set as absent. 
Any centroid mass showing a percentage of occurrences above 85% 
is set to exist. Any centroid mass that shows a percentage of 
occurrences between 15% and 85% is removed from the list. The 
unique m/z peaks identified in all S. aureus strains were validated if 
the observed phenotype (peak presence or absence) was coherent 
within 10 random spectra of each isolate. 
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Chapter Three 
 
RESULTS 
 
 
3.1 Identification of Discriminatory m/z Values of S. aureus  
 
 
To recognize discriminatory m/z values for identification of S. 
aureus, 14 S. aureus isolates were analyzed by MALDI-TOF MS. 
Spectra were taken over a mass (m/z) range of 800 to 20,000 with a 
focus mass of 5000 m/z. The majority of peaks were collected 
between masses 800 and 12,000 m/z (corresponding to 0.8 and 12 
kDa). 
 
The figure below represents a sample of the spectrum obtained from 
each isolate. 
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Figure 3. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 94). The 
m/z value shown on the x-axis corresponds to the molecular weight of proteins 
(Da) if the peak has a single positive charge. The percentage intensities of the 
peaks are shown on the y axis.  
 
 
The spectrum for each isolate can be found in the appendix. 
 
 
3.2 Data Analysis of Mass Spectra 
 
 
As mentioned before, 33 spectra were acquired for each S. aureus 
isolate (equivalent to 33 peak lists). The peak lists are processed 
using two programs developed for this purpose. Table 3 shows the 
average peaks obtained for each isolate.
 26 
 
Table 3: Masses observed for each S. aureus isolate from MALDI-TOF-MS analysis. “1” indicates presence 
and “0” indicates absence of a peak at a given strain 
Peak (m/z) SA16 SA103 SA125 SA126 SA34 SA36 SA94 SA128 SA23 SA24 SA57 SA79 SA89 SA95 
942.4756 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
1820.2366 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
2239.3262 0 0 0 0 1 0 0 1 0 0 0 0 1 0 
2300.2373 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
2362.5288 0 0 0 0 1 0 0 0 0 0 0 0 1 0 
2364.6428 0 0 0 0 1 0 0 1 0 0 0 0 1 0 
2367.4386 0 0 0 0 1 0 0 1 0 0 0 0 1 0 
2755.1882 1 0 0 0 0 1 1 0 0 1 0 0 0 0 
2755.9189 1 0 1 0 0 1 1 0 0 1 0 0 0 0 
2756.0125 1 0 1 1 0 1 1 0 0 1 0 0 0 0 
3216.0315 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3220.4548 1 1 1 1 1 0 1 1 1 1 1 1 1 1 
3220.8413 1 1 1 1 1 0 0 0 1 1 1 1 1 1 
3221.5632 1 1 1 1 0 0 0 0 1 1 1 1 1 1 
3446.6311 1 1 1 1 1 0 1 1 1 1 1 1 1 1 
3450.0225 1 1 1 1 1 0 1 1 1 1 1 1 1 1 
3454.8655 1 1 1 1 0 0 0 0 1 1 1 1 1 1 
3464.6926 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
4513.5945 0 0 0 0 0 0 1 1 0 0 0 1 1 0 
4822.9492 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4829.5181 1 1 1 1 1 1 1 0 1 1 1 1 1 1 
5250.5417 0 0 0 0 0 1 0 0 0 0 0 1 0 0 
5303.8354 0 0 0 0 0 0 0 0 1 0 1 1 0 0 
5314.8062 0 0 0 0 0 0 0 0 1 0 1 0 0 0 
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Peak (m/z) SA16 SA103 SA125 SA126 SA34 SA36 SA94 SA128 SA23 SA24 SA57 SA79 SA89 SA95 
5508.7493 1 0 0 0 0 0 1 0 0 0 0 0 0 0 
5509.5884 1 0 0 1 0 0 1 0 0 0 0 0 0 0 
5509.989 1 0 1 1 0 0 1 0 0 0 0 0 0 0 
5513.198 1 1 1 1 0 0 1 0 0 0 0 0 0 0 
5529.8896 1 1 1 1 1 0 0 1 1 1 1 1 1 1 
5537.3621 0 1 1 1 1 0 0 1 1 1 1 1 1 1 
5543.5898 0 1 1 1 1 0 0 0 1 1 1 1 1 1 
5546.1924 0 1 1 1 0 0 0 0 1 1 1 1 1 1 
6427.8223 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6437.812 1 1 1 1 1 1 1 0 1 1 1 1 1 1 
6579.4497 1 1 1 1 0 0 1 0 1 0 1 1 1 1 
6593.9648 1 1 1 1 0 0 0 0 0 0 0 0 0 1 
6595.6606 1 1 1 1 0 0 0 0 1 0 0 0 0 1 
6596.4404 1 1 1 1 0 0 0 0 1 0 1 0 0 1 
6596.7476 1 1 1 1 0 0 0 0 1 1 1 0 0 1 
6598.73 1 1 1 1 1 0 0 0 1 1 1 1 1 1 
6603.3701 1 1 1 1 1 0 1 1 1 1 1 1 1 1 
6612.1521 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6852.0515 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
6899.5774 1 1 1 1 1 0 1 1 1 1 1 1 1 1 
6910.4861 1 1 1 1 1 0 1 0 1 1 1 1 1 1 
8903.4185 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9643.9966 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11527.4260 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
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3.3 Data Validation and Analysis   
 
 
From the data obtained, we were able to identify 5 peaks (4823± 8, 
6428 ± 10, 6612 ± 11, 8903 ± 14, and 9644 ± 15 m/z) common to all 
the 14 S. aureus isolates. Peaks were 90% reproducible and a 
validation test was applied to the data analysis method. Ten readings 
were selected randomly from each isolate and verified visually for the 
presence of the above mentioned peaks. All the readings (a total of 
140 spectra) confirmed the presence of the 5 identified peaks. Figure 
7 presents an example of the validation test. 
 
 
Figure 4.  Data verification spectrum showing common peaks in all 14 S. 
aureus isolates. Stars represent the 5 peaks (4823± 8, 6428 ± 10, 6612 ± 11, 
8903 ± 14, and 9644 ± 15 m/z) identified. 
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3.4 Identification of Discriminatory m/z Values of S. epidermidis 
and E. coli 
 
 
Two additional bacteria (S. epidermidis 80 and E. coli J96 ATCC 
700336) were subjected to formic acid extraction and MALDI-TOF 
analysis following the same procedure and analysis applied on S. 
aureus. We were able to identify 23 peaks in E. coli isolate and 13 
peaks for S. epidermidis isolate. Table 4 represents the list of peaks 
for S. aureus, E. coli and S. epidermidis. 
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Table 4. List of m/z values common in each type of bacteria 
S. aureus S. epidermidis E. coli 
4823 803 845 
6428 845 883 
6612 3355 976 
8903 3754 1106 
9644 4308 2701 
 4914 3140 
 5135 3656 
 5366 4203 
 6607 4383 
 6717 4631 
 8135 4798 
 8900 5119 
 9659 5398 
  6321 
  6856 
  7310 
  7903 
  8394 
  8942 
  8973 
  9259 
  9590 
  10312 
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Four peaks from E. coli were identified to be ribosomal proteins. The 
list of these proteins is present in Table 5. 
 
Table 5. Comparison between peaks derived from our study to ribosomal 
proteins identified by Freiwald et al. (2009) 
E. coli J96  
ATCC 
700336 
Peaks from E. 
coli Freiwald et 
al. (2009) 
% 
Error 
Identified 
Ribosomal 
Proteins 
845       
883    
976       
1106    
2701       
3140    
3656       
4203    
4383     
4631    
4798       
5119    
5398 5381 0.3159 RS34 
6321 6316 0.0791 RL32 
6856       
7310    
7903     
8394 8370 0.2867 RS21 
8942       
8973    
9259       
9590    
10312 10300 0.1165 RS19 
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Table 6. Highlighted peaks represent the similarity identified between S. 
aureus and S. epidermidis 
S. aureus S. epidermidis % Error 
 803  
 845  
 3355  
 3754  
 4308  
 4914  
 5135  
 5366  
6612 6607 0.0841 
 6717  
 8135  
8903 8900 0.0390 
9644 9659 0.1531 
 
 
Peaks are considered to be similar when the % error between peaks 
of S. aureus and S. epidermidis is within our experimental error of 
0.31%. 
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Chapter Four 
 
DISCUSSION 
 
 
The sensitivity and robustness of MALDI-TOF have made it a very 
important proteomic tool for the fast identification of bacteria 
(Barbuddhe et al., 2008). Several studies have shown the potential of 
this technique to differentiate bacterial species. Dieckmann et al. 
(2008) have reported identification and classification of Salmonellae 
at both species and subspecies level. Williamson et al. (2008) showed 
the ability of MALDI-TOF MS to differentiate Streptococcus 
pneumonia strains. Regarding S. aureus, previous studies have 
confirmed the practicability and the high discriminatory power of 
MALDI-TOF as observed for the diverse S. aureus fingerprints 
obtained by this technique (Edwards-Jones et al., 2000). Moreover, 
Wolter et al. (2011) have attempted to discriminate major MRSA 
lineages by MALDI-TOF analysis of bacterial protein extracts. Some 
of their findings will be discussed later in this section. 
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In this study, bacterial extracts were prepared by formic acid 
extraction from S. aureus (4 MSSA and 10 MRSA), S. epidermidis 
80, and E. coli J96 ATCC 700336) isolates. The results obtained have 
shown highly reproducible spectra. Therefore we can conclude that 
the protocol is practical for routine applications. These results are in 
concordance with the findings of Wolters et al. (2011) regarding the 
protocol applied and reproducibility of spectra. 
 
Despite the 22-24 hours needed to subculture bacteria on TSA, we 
were able to obtain the results for MALDI-TOF analysis of all the 16 
bacteria within 3 hours. This time includes 45 minutes for sample 
preparation, 45 minutes for spotting and drying of sample/matrix on 
the target plate, 60 minutes for MALDI-TOF measurement, and 30 
minutes for data processing. On the other hand, genomic typing 
methods remain laborious and time consuming. For example, PFGE, 
which is known to be the "gold standard" for bacterial identification, 
needs 3-6 days for the results to be revealed (Murchan et al., 2003). 
Once developed, our proteomic approach will be much faster than the 
regular genomic methods. 
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Regarding S. aureus isolates, 48 unique peaks were found to be 
distributed among the 14 isolates. Table 3 represents the peaks 
identified and their absence or presence in each isolate. We noticed 
that out of the 48 peaks, 5 (4823, 6428, 6612, 8903, and 9644 m/z) 
were found to be conserved among all the S. aureus isolates. When 
these peaks are compared to the list of m/z values (4813, 6888 and 
9626) known to be highly conserved among S. aureus (Wolters et al., 
2011), we matched those at 4813 and 9626 m/z. Also, a validation 
test has confirmed the presence of these peaks in randomly selected 
spectra from each isolate, thus implying that our data analysis is 
valid. Figure 7 is an example of a spectrum showing the peaks 
common in all strains. Peaks are determined within a percentage error 
of 0.16% (1500 ppm) determined from the calibration standards. 
 
As mentioned earlier, all our S. aureus isolates were previously typed 
using various genomic methods (MLST, SCCmec typing and spa 
typing). The clonal complexes: CC 5 (SA 79, SA 125), CC 22 (SA 
103), CC 8 (SA 126), and CC 30 (SA 16, SA 94) used in this study 
have been found similar to those used by Wolters et al. (2011). We 
were able to identify 48 peaks distributed among the different clonal 
complexes. However, Wolter et al. (2011) have identified only 13 
peaks. Out of the 13 peaks that they have found to be distributed in 
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these clonal complexes, only 5 (4511, 5508, 5524, 6591, and 6612 
m/z) matched those we presented in Table 3. Although data found 
between the two studies show some similarity in the distribution of 
these peaks among the clonal complexes, variation still exists because 
of the different spa types that the same clonal complexes could have 
(Chambers & Deleo, 2009). Other reasons for these variations might 
be due to experimental variations and differences in analysis 
processing of data (Carbonnelle et al., 2011). Furthermore, a study 
performed by Wunschel et al. (2005) showed that differences in the 
various commercial instruments are a source for differences in results 
even if all the experimental parameters were held exactly the same. 
The nature of each peak has not been identified until now, but 
additional research done by Wolters et al. (2011) using data from 
genome-sequenced reference S. aureus strains, revealed that the 4 
peaks at m/z 3216, 3447, 4823, and 6428 in Table 3 are ribosomal 
proteins (via personal communication with Wolters group). However, 
further investigation is still needed to reveal the exact identity of the 
other peaks. 
 
A study by Bittar et. al. (2009) revealed that S. aureus isolates 
carrying the PVL toxin can be directly identified using MALDI-TOF 
MS. They have identified a peak at 4448 m/z that was thought to be a 
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marker for the presence of the PVL toxin. However this approach 
failed when it was applied on four of our S. aureus isolates, namely 
SA 23, SA 16, SA 57, and SA 125, carrying the PVL toxin. Thus we 
conclude that there is no correlation between peak at 4448 m/z value 
and PVL toxin. One possible explanation is that this peak is excluded 
from the list of Table 3 because it failed to match the stringent criteria 
in the program‟s data analysis. However, when searching through the 
unprocessed data, we noticed that this peak at 4448 m/z is present in 
2 strains (SA 103 and SA 34) lacking the PVL toxin. Another 
possible explanation for this difference is that we performed formic 
acid extraction of proteins and not whole cell preparation as 
performed by Bittar et al. (2009). But Szabados et al. (2011) 
performed MALDI-TOF MS on whole cells and could not find any 
relation between the peak at 4448 m/z and presence of the PVL toxin, 
therefore supporting our findings. 
 
To determine whether the 5 common identified peaks are unique to S. 
aureus, two additional bacteria, S. epidermidis 80 and E. coli J96 
ATCC 700336, were subjected to MALDI-TOF analysis following 
the same procedure of formic acid extraction and analysis as applied 
on S. aureus. It is important to note that S. epidermidis are 
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evolutionary the closest species to S. aureus, while E. coli belongs to 
a genus evolutionary far from the genus Staphylococcus. 
 
Regarding MALDI-TOF analysis of E. coli, we have identified 23 
peaks completely conserved in all the spectra obtained from the data 
analysis. To determine the nature of these peaks presented in Table 4, 
we compared our peak list to the results obtained by Freiwald & 
Sauer (2009) on the phylogenetic differentiation of bacteria by mass 
spectrometry. We were able to match 4 peaks at m/z 5398, 6320, 
8394, and 10312 as E. coli ribosomal proteins RS 34, RL 32, RS 21, 
and RS 19, respectively (Table 5). 
 
As for the MALDI-TOF analysis of S. epidermidis, 13 peaks were 
found to be present among all the spectra analyzed. But this time, 
none of the peaks identity was determined. One main reason is 
absence of a database access (such as BioTyper 2.0 and 
ClinProTools
TM
 2.0) for bacterial identification.  
 
Of the 5 peaks found to be common to all S. aureus isolates, 3 were 
found to be present in S. epidermidis (Table 6). However, none were 
found to be present in E. coli. Thus we can say that the 3 peaks (6612, 
8903 and 9644 m/z) found in common between S. aureus and S. 
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epidermidis are unique for the genus Staphylococcus and the 2 peaks 
(4823 and 6428 m/z) are unique for the species S. aureus. Also, the 
developed program is designed to match an unknown sample to one 
of the 14 S. aureus isolates used in this study. So when we tested the 
samples related to S. epidermidis, the highest match obtained with 
one of our S. aureus isolate was around 39%. But when E. coli was 
tested, maximum match was close to 8%.  
 
Furthermore, if we look at Table 3, we noticed that 5 isolates have 
unique peaks specific only for them. SA 34, SA 103, SA 16, SA 36, 
and SA 79 show one unique peak at 942, 2300, 3464, 6852, and 
11527 m/z respectively. Since each of these strains belongs to a 
unique clonal complex and spa type, we were able to identify peaks 
specific for S. aureus at the strain level. However, further 
investigations are still necessary to identify peaks specific for all the 
other strains. Finally, it is important to note that due to the lack of 
software, we were unable to correlate the results obtained from our 
proteomic and genomic data. 
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Chapter Five 
 
Conclusion 
 
 
In conclusion, monitoring the spread of S. aureus is an essential step 
for initiation of targeted infection control measures against this 
pathogen. In this study, we were able to prove that MALDI-TOF can 
be a promising proteomic tool for fast and reliable identification of S. 
aureus. The highly reproducible data obtained and simple sample 
preparations have given MALDI-TOF an advantage over regular 
genomic methods. Moreover, the identification and validation of 3 
peaks specific to the genus Staphylococcus and 2 peaks specific for S. 
aureus species, has proved that the program developed is powerful 
and effective in analyzing high-through put data obtained from 
MALDI-TOF analysis of bacterial protein extracts. However, 
program revision need to be undertaken to allow for analysis of 
bacterial strains of the same species. Also, Future work will address 
the Tandem-MS of the unique peaks to determine their nature, the 
creation of a database from other bacterial groups to help identify 
unknown bacteria and the correlation between both genomic and 
proteomic data obtained.  
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Chapter Seven 
 
Appendices  
 
Appendix I 
 
 
Figure I-a. Layout of the first step to be applied in program 1. Row 1 represents the percentage error for each 
spot, Row 2 indicates the location of the spot on the MALDI target and the other rows refer to the m/z values. 
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Figure I-b. Layout of the second step to be applied in program 1. Row 1 represents the number of the spot. 
Column 1 refers to the centroid mass (m/z value) values and “1” indicates presence of a peak. 
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Figure I-c. Layout of the first step to be applied in program 2. Row 1 represents the percentage error for each 
spot; Row 2 indicates each S. aureus strain and the other rows refer to the m/z values with their percentage of 
occurrence. 
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Figure I-d. Layout of the second step to be applied in program 2. Row 1 indicates each S. aureus strain and 
the other rows refer to the percentage of occurrence of each centroid mass indicated in column A. 
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Figure I-e. Layout of the third step to be applied in program 2. Row 1 indicates each S. aureus strain and the 
other rows indicates presence or absence of each centroid mass indicated in column A. Highlighted rows are 
the values to be present in all strains including matrix. 
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Appendix II 
 
 
Figure II-a. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 128). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis.  
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Figure II-b. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 36). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-c. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 34). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-d. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 24). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-e. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 95). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-f. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 23). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-g. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 89). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-h. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 57). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis.   
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Figure II-i. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 79). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-j. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 16). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-k. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 103). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-l. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 125). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-m. MALDI-TOF MS spectrum of FAE S. aureus isolate (SA 126). The m/z value shown on the x-axis 
corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
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Figure II-n. MALDI-TOF MS spectrum of FAE Escherichia coli J96  ATCC 700336). The m/z value shown on 
the x-axis corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The 
percentage intensities of the peaks are shown on the y-axis. 
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Figure II-o. MALDI-TOF MS spectrum of FAE Staphylococcus epidermidis 80. The m/z value shown on the x-
axis corresponds to the molecular weight of the peak (Da) if it carries a single positive charge. The percentage 
intensities of the peaks are shown on the y-axis. 
